BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

91 related articles for article (PubMed ID: 6478394)

  • 1. Interstitial misonidazole. A preliminary report on a new perspective in clinical radiation sensitization and hypoxic cell chemotherapy.
    Sealy R; Korrubel J; Cridland S; Blekkenhorst G
    Cancer; 1984 Oct; 54(8):1535-40. PubMed ID: 6478394
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A comparison of the tumour concentrations obtainable with misonidazole and Ro 03-8799.
    Dische S; Saunders MI; Bennett MH; Dunphy EP; Des Rochers C; Stratford MR; Minchinton AI; Wardman P
    Br J Radiol; 1986 Sep; 59(705):911-7. PubMed ID: 3756388
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Large fraction radiotherapy plus misonidazole for treatment of advanced lung cancer: report of a phase I/II trial.
    Simpson JR; Perez CA; Phillips TL; Concannon JP; Carella RJ
    Int J Radiat Oncol Biol Phys; 1982 Feb; 8(2):303-8. PubMed ID: 7085386
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Clinical evaluation of hypoxic cell sensitizer (Misonidazole)].
    Asakawa H; Watarai J; Hoshino T
    Gan To Kagaku Ryoho; 1984 Jun; 11(6):1225-30. PubMed ID: 6732250
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Effect of even or uneven dose fractionation regime on murine squamous cell carcinoma with combined use of misonidazole].
    Yasunaga T; Takada C; Takahashi M; Okada S; Sakamoto K
    Nihon Igaku Hoshasen Gakkai Zasshi; 1983 Oct; 43(10):1224-31. PubMed ID: 6672751
    [No Abstract]   [Full Text] [Related]  

  • 6. Clinical experience with misonidazole: high dose fractions versus daily low doses.
    Kogelnik HD
    Cancer Clin Trials; 1980; 3(2):179-86. PubMed ID: 6253098
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Clinical studies of combined therapy of radiation and local injection of misonidazole].
    Hong SS; Abe Y; Isobe Y; Yamakawa M; Kaneta K; Kawaguchi T; Matsuzawa T; Umegaki Y
    Nihon Igaku Hoshasen Gakkai Zasshi; 1983 May; 43(5):675-84. PubMed ID: 6622246
    [No Abstract]   [Full Text] [Related]  

  • 8. Final report on the United States Phase I Clinical Trial of the hypoxic cell radiosensitizer, misonidazole (Ro-07-0582; NSC #261037).
    Phillips TL; Wasserman TH; Johnson RJ; Levin VA; VanRaalte G
    Cancer; 1981 Oct; 48(8):1697-704. PubMed ID: 6269723
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Biological studies of proton irradiation under combination with a hypoxic cell sensitizer].
    Majima H; Ando K; Koike S; Furukawa S; Hiraoka T; Kawachi K; Kanai T
    Nihon Igaku Hoshasen Gakkai Zasshi; 1982 Apr; 42(4):398-405. PubMed ID: 6289262
    [No Abstract]   [Full Text] [Related]  

  • 10. Radiosensitizing effect of misonidazole in fractionated gamma-ray treatment of a human malignant melanoma grown in athymic nude mice.
    Rofstad EK; Brustad T
    Br J Radiol; 1979 May; 52(617):393-7. PubMed ID: 444837
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Intravesical administration of misonidazole in bladder carcinoma.
    Ghoneim MA; Shaaban AA; El-Merzabani MM; Awaad HK; El Gammal S
    Acta Radiol Oncol; 1983; 22(3):177-81. PubMed ID: 6312756
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Radical irradiation and misonidazole in the treatment of T2 grade III and T3 bladder cancer.
    Abratt RP; Sealy R; Tucker RD; Williams MA; Barnes DR; Johnson MB; Green JA; Cridland JS
    Int J Radiat Oncol Biol Phys; 1983 May; 9(5):629-32. PubMed ID: 6853264
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The topical use of misonidazole in bladder cancer.
    Awwad HK; Abd El Moneim H; Abd El Baki H; Omar S; El Merzabani M; Farag HI
    Prog Clin Biol Res; 1983; 132D():305-16. PubMed ID: 6634802
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Misonidazole combined with radiotherapy in the treatment of inoperable squamous cell carcinoma of the lung. A double-blind randomized trial.
    Panduro J; Kjaer M; Wolff-Jensen J; Hansen HH
    Cancer; 1983 Jul; 52(1):20-4. PubMed ID: 6303553
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pilot study of radiotherapy with misonidazole in head and neck cancer.
    Paterson IC; Dawes PJ; Henk JM; Moore JL
    Clin Radiol; 1981 Mar; 32(2):225-9. PubMed ID: 7214840
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of combined misonidazole and d(50)-Be neutrons on a human melanoma transplanted into nude mice.
    Guichard M; Gueulette J; Octave-Prignot M; Wambersie A; Malaise EP
    Radiology; 1980 Aug; 136(2):479-84. PubMed ID: 7403527
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Radiosensitizing effects of nitroimidazole derivative, KIN-804].
    Tada T
    Nihon Igaku Hoshasen Gakkai Zasshi; 1995 Jan; 55(1):70-5. PubMed ID: 7899069
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Misonidazole in fractionated radiotherapy: are many small fractions best?
    Denekamp J; McNally NJ; Fowler JF; Joiner MC
    Br J Radiol; 1980 Oct; 53(634):981-90. PubMed ID: 7426922
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Multiple daily fractionation (MDF) radiotherapy in association with hyperthermia and/or misonidazole: experimental and clinical results.
    Arcangeli G; Barocas A; Mauro F; Nervi C; Spanò M; Tabocchini A
    Cancer; 1980 Jun; 45(11):2707-11. PubMed ID: 7379004
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Radiotherapy using the hypoxic cell sensitizer Ro 03-8799 in malignant melanoma.
    Dische S
    Radiother Oncol; 1987 Oct; 10(2):111-6. PubMed ID: 2447612
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.